Back

Impact of rhythm- vs. rate-control strategy for atrial fibrillation at the emergency department

4 March 2019 (10:36 - 10:42)
Organised by:
Congress Presentation Part of: Moderated Poster 8: Arrhythmias Rhythm Control, Cardioversion ACVC Premium Access Acute Cardiovascular Care 2019

About the speaker

Photo
Doctor Ricardo Rubini-Costa

Virgen de las Nieves University Hospital, Granada (Spain)

6 More presentations in this session

Presentation thumbnail
Chronic digoxin utilisation in patients with atrial fibrillation is associated with hospitalisation for de novo acute heart failure
Doctor M. Beringuilho (Amadora, PT)
Presentation thumbnail
Left atrium major axis measure as an early predictor of atrial fibrillation recurrence after electric cardioversion
Presentation thumbnail
Utilisation of proton pump inhibitors in patients with atrial fibrillation is associated with hospitalisation for de novo acute heart failure
Presentation thumbnail
Feasibility, efficacy, and safety of percutaneous left atrial closure in patients with non-valvular atrial fibrillation who have a contraindication to oral anticoagulation:a retrospective study cohort
Mr N. Kanyep (Paris, FR)
Abstract
Presentation thumbnail
Predictive variables of persistence and recurrence in drug-induced atrioventricular block: a multicenter study
Doctor R. Rubini-Costa (Granada, ES)
Abstract Slides

Access the full session

Session thumbnail
Moderated Poster 8: Arrhythmias

The Event

Event poster

Acute Cardiovascular Care 2019

4 March 2019 10:36 CET
You may be interested in
thumbnail
Congress Presentation
Rhythm control versus rate control in patients with atrial fibrillation and heart failure across the left ventricular ejection fraction spectrum
29 June 2021
thumbnail
Congress Presentation
An aggressive electrophysiologist-guided rhythm control strategy significantly reduces hospital admissions in patients presenting with atrial fibrillation in the emergency department.
12 April 2026
thumbnail
Congress Presentation
The rhythm at admission had influenced in the time of acute coronary syndromes?
29 June 2021
thumbnail
Congress Presentation
New-onset atrial fibrillation in the ICU: a temporary disturbance or a lasting burden?
21 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources